Table 1 Demographic data of participants.

From: Evaluation of transorbital sonography measures of optic nerve diameter in the context of global and regional brain volume in multiple sclerosis

 

Healthy controls

RRMS patients

# of subjects (# of eyes)

25 (50)

45 (90)

Females

13

31

Age (years)

37.72 ± 14.8 (range: 21.6—60.4)

40.97 ± 9.8 (range: 22.5–58.5)

Disease duration (years)

–

8.945 ± 5.88 (range: 0.4–24)

EDSS

–

1.211 ± 1.094 (range: 0—4)

Treatment regimen

–

GA—29%

Te—22%

F—22%

A—9%

IFNb—7%

DF—7%

N—2%

P—2%

  1. Mean ± standard deviation (SD) are described. Range intervals are as follows: age: 21.6–60.4 years for controls, 22.5–58.5 years for patients; disease duration: 0.4–24 years; EDSS: 0–4. Treatment regimen abbreviations: GA glatiramer-acetate, Te teriflunomide, F fingolimod, A alemtuzumab, IFNb interferon beta 1a, DF dimethyl fumarate, N natalizumab, P pramipexole.
Back to article page